Hidrosmin(CAS:120250-44-4)

Hidrosmin (CAS: 120250-44-4) is a semi-synthetic flavonoid derivative, a functional pharmaceutical raw material obtained by hydroxylation modification of diosmin, a natural flavonoid compound. On the basis of retaining the core pharmacological activities of diosmin, it optimizes the physical and chemical properties and bioavailability, becoming a high-quality pharmaceutical ingredient for improving venous circulation and maintaining vascular health. This product has stable chemical structure, high safety and mild side effects. With clear vascular maintenance effects, it is widely used in pharmaceutical R&D, venous health preparations, soothing care and other fields, and is one of the indispensable core pharmaceutical raw materials in clinical and big health fields.

In terms of physical and chemical properties, Hidrosmin appears as pale yellow crystalline powder, odorless, tasteless and non-irritating, with stable overall physical and chemical properties and not easy to undergo oxidative degradation. Compared with diosmin, its solubility has been significantly improved: it is soluble in organic solvents such as methanol, ethanol and dimethyl sulfoxide (DMSO), slightly soluble in water, and can be adapted to various formulation processes without complex solvent compounding, suitable for water-based and oil-based formulation systems. The melting point of this product is about 220-225℃, the density is about 1.52g/cm³, and the specific rotation meets the pharmaceutical standards. It can be stored stably under normal temperature, dry, sealed and light-proof conditions. It is prone to moisture absorption and caking when exposed to strong light, high temperature or high humidity for a long time. Therefore, it must be stored in sealed, light-proof, dry and cool conditions, away from heat sources and oxidants, to ensure the purity and activity stability of the product, which meets the pharmaceutical grade standards.

In terms of production process, Hidrosmin is prepared by a semi-synthetic process. Using natural diosmin as the raw material, chemical modification is carried out through directional hydroxylation reaction to optimize the molecular structure and enhance its biological activity and solubility. The production process strictly follows the pharmaceutical grade production standards, which is sterile throughout without producing toxic or harmful substances, mainly including precision steps such as raw material pretreatment, hydroxylation modification, separation and purification, refining and crystallization, drying, and sterile packaging. The raw material uses high-purity diosmin (purity ≥98%), and after directional catalytic hydroxylation reaction, impurities are removed by column chromatography, recrystallization and other methods to stably produce high-purity Hidrosmin products with a purity of more than 98% and impurity content controlled below 2%, which meets the relevant industry standards of pharmaceutical grade and can meet the needs of large-scale pharmaceutical production. The packaging adopts sterile sealed containers, suitable for pharmaceutical R&D and formulation production.

The core value of Hidrosmin lies in its excellent vascular maintenance effect. As a powerful venous circulation improver, its pharmacological activities have been verified by a large number of clinical experiments. It is highly safe and well-tolerated. Only a few people may experience slight gastrointestinal discomfort, which does not require interruption of use and is suitable for long-term medicinal use. Its core functions are concentrated in improving venous circulation, strengthening vascular walls, reducing capillary fragility, and also having antioxidant and anti-inflammatory activities: first, it can improve venous reflux disorders, reduce venous congestion and edema, relieve symptoms such as limb heaviness, soreness and numbness, and has a significant auxiliary improvement effect on lower extremity varicose veins and venous insufficiency.

Secondly, it can strengthen the toughness of vascular walls, enhance the elasticity of vascular walls, reduce capillary permeability, reduce the risk of vascular rupture and bleeding, and has a good improvement effect on problems such as fragile capillaries and increased fragility; in addition, its antioxidant activity can scavenge free radicals in the body, reduce oxidative stress damage to blood vessels, delay vascular aging, and its anti-inflammatory activity can inhibit the release of inflammatory factors, relieve vascular inflammatory reactions, and assist in protecting vascular health. Compared with diosmin, Hidrosmin has higher bioavailability, stronger pharmacological activity and faster onset of action, making it more suitable for pharmaceutical formulation R&D.

In terms of application scenarios, Hidrosmin mainly focuses on the pharmaceutical field, and gradually expands to the big health care field. In the pharmaceutical field, it is the core raw material for preparing venous circulation improving drugs, auxiliary therapeutic drugs for anorectal diseases, and vascular protective drugs, used to relieve symptoms related to lower extremity varicose veins, venous insufficiency, hemorrhoidal varicose veins, etc., with wide clinical application; in the big health field, it can be used as a functional raw material, added to venous health dietary supplements and soothing care products, suitable for people who sit or stand for a long time and middle-aged and elderly people, to assist in maintaining blood vessels and improving limb discomfort; in addition, it can also be used as a pharmaceutical intermediate for the R&D of new vascular protective drugs, further expanding its pharmaceutical value.

With the increasing attention paid to venous health and the continuous development of the pharmaceutical industry, the demand for safe and effective vascular maintenance pharmaceutical raw materials continues to rise. Hidrosmin, with its clear efficacy, good safety and mature production process, has a growing market demand year by year. In the future, with the continuous optimization of production processes, its purity and output will be further improved, its application scenarios will be continuously expanded, and more pharmacological effects will be further explored, making it play a greater role in the pharmaceutical and big health fields and provide better pharmaceutical raw material support for vascular health.